ScanTech AI Systems Inc. (STAI): Nasdaq/NYSE listing notice — ScanTech AI receives Nasdaq deficiency notice for bid price below $1.00

ScanTech AI Systems Inc.

Nasdaq notice on July 10, 2025; stock below $1.00 for 30 consecutive days (May 23 – July 8).
Company has 180 calendar days (until Jan 6, 2026) to regain compliance.
If bid price closes at $1.00+ for 10 consecutive trading days, compliance will be confirmed.
If not cured, Company may transfer to Nasdaq Capital Market or effect a reverse stock split.
No immediate impact on listing or trading of STAI common stock.

item 3.01 item 8.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.95

ScanTech AI Systems Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 5450(a)(1)

Exact text from the filing

July 10, 2025, ScanTech AI Systems Inc. (the “Company”) received a written notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market (“Nasdaq”) indicating that the Company is not in compliance with the $1.00 minimum bid price requirement set forth in Nasdaq Listing Rule 5450(a)(1) (the “Bid Price Requirement”) for continued listing on The Nasdaq Global Market. The Nasdaq Listing Rules require listed securities to maintain a minimum bid price of $1.00 per share, and, based upon the closing bid price of the Company’s common stock for the 30 consecutive business

View on SEC.gov

20 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

ScanTech AI Systems Inc. filing history →

Source: SEC EDGAR

accession 0001104659-25-068105

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.